Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stratum corneum is the outermost layer of the epidermis, acting as the body's primary physical and chemical barrier against environmental insults. It consists of corneocytes, which are dead, flattened cells filled with a dense network of keratin intermediate filaments (primarily KRT1 and KRT10) and encased in a highly cross-linked cornified envelope composed of proteins like filaggrin, loricrin, and involucrin (StatPearls, NBK513299). These proteins provide structural rigidity and are essential for maintaining skin hydration and preventing transepidermal water loss (PubMed, 23945662). In various dermatological conditions such as psoriasis and ichthyosis, abnormal keratinization leads to the accumulation of these proteins, resulting in thickened, scaly skin (NIH, Filaggrin). Therapeutic strategies targeting these proteins often utilize keratolytic agents like salicylic acid or urea, which chemically disrupt the protein structures or the 'intercellular cement' to promote the shedding of excess cornified tissue (PubChem, Salicylic acid). Additionally, retinoids are used to modulate the gene expression of these proteins to normalize the differentiation process of keratinocytes (Journal of Clinical and Aesthetic Dermatology, Keratolytics).
Keratolytic agents interact with these proteins by increasing hydration, which causes the cornified epithelium to swell and soften, or by disrupting the intercellular desmosomes and protein-lipid matrices that hold corneocytes together, thereby facilitating desquamation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin and other stratum corneum proteins (SC proteins).